David Santos
Equibles does not estimate personal net worth.
Get an email with a short summary when Rigel Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get RIGL alertsAbout David Santos
The proxy statement of Rigel Pharmaceuticals Inc reports total compensation of $1,382,463 for David Santos in fiscal 2024, including a base salary of $496,080. Disclosed compensation is on record for 6 fiscal years. Rigel Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rigel Pharmaceuticals Inc includes Raul R. Rodriguez (CEO and Board Member), Raul Rodriguez (CEO and Board Member), Dean Schorno (CFO) and 7 others.
Affiliation history
-
Rigel Pharmaceuticals Inc (RIGL)
Proxy statement
CurrentStart not stated–present
Last confirmed April 3, 2026
Company network
Leadership on record at Rigel Pharmaceuticals Inc
- Raul R. Rodriguez CEO, Board Member
- Raul Rodriguez CEO, Board Member
- Dean Schorno CFO
- Raymond Furey General Counsel
- Alison Hannah Board Member
- Alison Hannah, M.D. Board Member
- Alison L. Hannah Board Member
- Brian L. Kotzkin Board Member
- Gary A. Lyons Board Member
- Gregg A. Lapointe Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President and Chief Commercial Officer | $496,080 | $1,382,463 |
| 2023 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President and Chief Commercial Officer | $477,000 | $1,341,791 |
| 2022 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President and Chief Commercial Officer | $450,000 | $1,124,415 |
| 2020 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President and Chief Commercial Officer | $163,726 | $1,190,602 |
| 2019 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President and Chief Commercial Officer | — | — |
| 2018 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President and Chief Commercial Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.